• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶-2损害猪再灌注心肌梗死模型中冠状动脉内递送间充质干细胞的归巢:与心肌内细胞递送的比较。

Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery.

作者信息

Zlabinger Katrin, Lukovic Dominika, Hemetsberger Rayyan, Gugerell Alfred, Winkler Johannes, Mandic Ljubica, Traxler Denise, Spannbauer Andreas, Wolbank Susanne, Zanoni Gerald, Kaun Christoph, Posa Aniko, Gyenes Andrea, Petrasi Zsolt, Petnehazy Örs, Repa Imre, Hofer-Warbinek Renate, de Martin Rainer, Gruber Florian, Charwat Silvia, Huber Kurt, Pavo Noemi, Pavo Imre J, Nyolczas Noemi, Kraitchman Dara L, Gyöngyösi Mariann

机构信息

Department of Cardiology, Medical University of Vienna, Vienna, Austria.

Ludwig Boltzmann Institute for Clinical and Experimental Traumatology/AUVA Research Center Austrian Cluster for Tissue Regeneration, Vienna, Austria.

出版信息

Front Bioeng Biotechnol. 2018 Apr 4;6:35. doi: 10.3389/fbioe.2018.00035. eCollection 2018.

DOI:10.3389/fbioe.2018.00035
PMID:29670878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5893806/
Abstract

BACKGROUND

Intracoronary (IC) injection of mesenchymal stem cells (MSCs) results in a prompt decrease of absolute myocardial blood flow (AMF) with late and incomplete recovery of myocardial tissue perfusion. Here, we investigated the effect of decreased AMF on oxidative stress marker matrix metalloproteinase-2 (MMP-2) and its influence on the fate and homing and paracrine character of MSCs after IC or intramyocardial cell delivery in a closed-chest reperfused myocardial infarction (MI) model in pigs.

METHODS

Porcine MSCs were transiently transfected with Ad-Luc and Ad-green fluorescent protein (GFP). One week after MI, the GFP-Luc-MSCs were injected either IC (group IC, 11.00 ± 1.07 × 10) or intramyocardially (group IM, 9.88 ± 1.44 × 10). AMF was measured before, immediately after, and 24 h post GFP-Luc-MSC delivery. bioluminescence signal was used to identify tissue samples containing GFP-Luc-MSCs. Myocardial tissue MMP-2 and CXCR4 receptor expression (index of homing signal) were measured in bioluminescence positive and negative infarcted and border, and non-ischemic myocardial areas 1-day post cell transfer. At 7-day follow-up, myocardial homing (cadherin, CXCR4, and stromal derived factor-1alpha) and angiogenic [fibroblast growth factor 2 (FGF2) and VEGF] were quantified by ELISA of homogenized myocardial tissues from the bioluminescence positive and negative infarcted and border, and non-ischemic myocardium. Biodistribution of the implanted cells was quantified by using Luciferase assay and confirmed by fluorescence immunochemistry. Global left ventricular ejection fraction (LVEF) was measured at baseline and 1-month post cell therapy using magnet resonance image.

RESULTS

AMF decreased immediately after IC cell delivery, while no change in tissue perfusion was found in the IM group (42.6 ± 11.7 vs. 56.9 ± 16.7 ml/min,  = 0.018). IC delivery led to a significant increase in myocardial MMP-2 64 kD expression (448 ± 88 vs. 315 ± 54 intensity × mm,  = 0.021), and decreased expression of CXCR4 (592 ± 50 vs. 714 ± 54 pg/tissue/ml,  = 0.006), with significant exponential decay between MMP-2 and CXCR4 ( = 0.679,  < 0.001). FGF2 and VEGF of the bioluminescence infarcted and border zone of homogenized tissues were significantly elevated in the IM goups as compared to IC group. LVEF increase was significantly higher in IM group (0.8 ± 8.4 vs 5.3 ± 5.2%,  = 0.046) at the 1-month follow up.

CONCLUSION

Intracoronary stem cell delivery decreased AMF, with consequent increase in myocardial expression of MMP-2 and reduced CXCR4 expression with lower level of myocardial homing and angiogenic factor release as compared to IM cell delivery.

摘要

背景

冠状动脉内(IC)注射间充质干细胞(MSC)可导致心肌绝对血流量(AMF)迅速下降,且心肌组织灌注恢复延迟且不完全。在此,我们在猪的闭胸再灌注心肌梗死(MI)模型中,研究了AMF降低对氧化应激标志物基质金属蛋白酶-2(MMP-2)的影响,以及IC或心肌内细胞递送后其对MSC的命运、归巢和旁分泌特性的影响。

方法

用腺病毒载体介导的荧光素酶(Ad-Luc)和绿色荧光蛋白(Ad-GFP)对猪MSC进行瞬时转染。MI后1周,将绿色荧光蛋白-荧光素酶-MSC分别经IC(IC组,11.00±1.07×10)或心肌内(IM组,9.88±1.44×10)注射。在注射绿色荧光蛋白-荧光素酶-MSC前、注射后即刻及注射后24小时测量AMF。利用生物发光信号识别含有绿色荧光蛋白-荧光素酶-MSC的组织样本。在细胞转移后1天,测量生物发光阳性和阴性梗死区、边缘区及非缺血心肌区域的心肌组织MMP-2和CXCR4受体表达(归巢信号指数)。在7天随访时,通过酶联免疫吸附测定法(ELISA)对生物发光阳性和阴性梗死区、边缘区及非缺血心肌的匀浆心肌组织中的心肌归巢相关因子(钙黏蛋白、CXCR4和基质细胞衍生因子-1α)和血管生成相关因子[成纤维细胞生长因子2(FGF2)和血管内皮生长因子(VEGF)]进行定量分析。通过荧光素酶测定法定量植入细胞的生物分布,并通过荧光免疫化学法进行确认。使用磁共振成像在基线及细胞治疗后1个月测量整体左心室射血分数(LVEF)。

结果

IC组细胞注射后AMF即刻下降,而IM组组织灌注无变化(42.6±11.7 vs. 56.9±16.7 ml/min,P = 0.018)。IC组注射导致心肌MMP-2 64 kD表达显著增加(448±88 vs. 315±54光密度×mm,P = 0.021),CXCR4表达降低(592±50 vs. 714±54 pg/组织/ml,P = 0.006),MMP-2与CXCR4之间呈显著指数衰减关系(r = 0.679,P < 0.001)。与IC组相比,IM组匀浆组织生物发光梗死区和边缘区的FGF2和VEGF显著升高。在1个月随访时,IM组LVEF增加显著高于IC组(0.8±8.4 vs 5.3±5.2%,P = 0.046)。

结论

与心肌内细胞递送相比,冠状动脉内干细胞递送降低了AMF,导致心肌MMP-2表达增加、CXCR4表达降低,心肌归巢和血管生成因子释放水平降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/945515d0d018/fbioe-06-00035-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/83a6c5d87d40/fbioe-06-00035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/5d10dbaa8596/fbioe-06-00035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/806e17cab975/fbioe-06-00035-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/0830bc85d901/fbioe-06-00035-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/4360aa93fefa/fbioe-06-00035-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/945515d0d018/fbioe-06-00035-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/83a6c5d87d40/fbioe-06-00035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/5d10dbaa8596/fbioe-06-00035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/806e17cab975/fbioe-06-00035-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/0830bc85d901/fbioe-06-00035-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/4360aa93fefa/fbioe-06-00035-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f5b/5893806/945515d0d018/fbioe-06-00035-g006.jpg

相似文献

1
Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery.基质金属蛋白酶-2损害猪再灌注心肌梗死模型中冠状动脉内递送间充质干细胞的归巢:与心肌内细胞递送的比较。
Front Bioeng Biotechnol. 2018 Apr 4;6:35. doi: 10.3389/fbioe.2018.00035. eCollection 2018.
2
Hypoxia-inducible factor 1-alpha release after intracoronary versus intramyocardial stem cell therapy in myocardial infarction.心肌梗死后冠状动脉内与心肌内干细胞治疗后缺氧诱导因子 1-α的释放。
J Cardiovasc Transl Res. 2010 Apr;3(2):114-21. doi: 10.1007/s12265-009-9154-1. Epub 2009 Dec 23.
3
Delayed recovery of myocardial blood flow after intracoronary stem cell administration.冠状动脉内干细胞给药后心肌血流的延迟恢复。
Stem Cell Rev Rep. 2011 Sep;7(3):616-23. doi: 10.1007/s12015-010-9213-7.
4
Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium.间充质干细胞上CXCR4的过表达增强梗死心肌中的肌血管生成。
J Mol Cell Cardiol. 2008 Feb;44(2):281-92. doi: 10.1016/j.yjmcc.2007.11.010. Epub 2007 Dec 7.
5
A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.一项评估心肌梗死后三种间充质干细胞递送方法的定量随机研究。
Eur Heart J. 2006 May;27(9):1114-22. doi: 10.1093/eurheartj/ehi818. Epub 2006 Mar 1.
6
Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.人脐带间充质基质细胞改善慢性心肌缺血猪模型的左心室功能、灌注及重塑
Stem Cells Transl Med. 2016 Aug;5(8):1004-13. doi: 10.5966/sctm.2015-0298. Epub 2016 Jun 22.
7
Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9.过表达 CXCR4 的间充质干细胞通过释放基质金属蛋白酶-9 减轻心肌梗死后的重构。
Stem Cells Dev. 2012 Mar 20;21(5):778-89. doi: 10.1089/scd.2011.0126. Epub 2011 Jul 22.
8
Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.缺氧诱导因子-1α的心肌转染及间充质干细胞的共移植增强实验性心肌梗死大鼠的心脏修复
Stem Cell Res Ther. 2014 Feb 7;5(1):22. doi: 10.1186/scrt410.
9
Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression.经皮心肌内注射经转基因报告基因表达修饰的自体猪间充质干细胞的系列无创体内正电子发射断层扫描追踪。
Circ Cardiovasc Imaging. 2008 Sep;1(2):94-103. doi: 10.1161/CIRCIMAGING.108.797449. Epub 2008 Jul 30.
10
Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.骨源巢蛋白阳性间充质干细胞通过梗死心肌后募集心脏内皮细胞改善心功能。
Stem Cell Res Ther. 2019 Apr 27;10(1):127. doi: 10.1186/s13287-019-1217-x.

引用本文的文献

1
Low-Intensity Pulsed Ultrasound Enhanced Adipose-Derived Stem Cell-Mediated Angiogenesis in the Treatment of Diabetic Erectile Dysfunction through the Piezo-ERK-VEGF Axis.低强度脉冲超声通过压电-ERK-血管内皮生长因子轴增强脂肪来源干细胞介导的血管生成以治疗糖尿病性勃起功能障碍
Stem Cells Int. 2022 Jul 29;2022:6202842. doi: 10.1155/2022/6202842. eCollection 2022.
2
Cell-Based HIF1α Gene Therapy Reduces Myocardial Scar and Enhances Angiopoietic Proteome, Transcriptomic and miRNA Expression in Experimental Chronic Left Ventricular Dysfunction.基于细胞的HIF1α基因疗法可减少实验性慢性左心室功能障碍中的心肌瘢痕,并增强血管生成蛋白质组、转录组和miRNA表达。
Front Bioeng Biotechnol. 2022 May 12;10:767985. doi: 10.3389/fbioe.2022.767985. eCollection 2022.
3

本文引用的文献

1
Mesenchymal stem cells for cardiac repair: are the actors ready for the clinical scenario?间质干细胞用于心脏修复:演员们是否已经准备好迎接临床场景?
Stem Cell Res Ther. 2017 Oct 27;8(1):238. doi: 10.1186/s13287-017-0695-y.
2
Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.基于肽的基质金属蛋白酶-2抑制剂的缓释可减轻心肌梗死后的不良心脏重塑并改善心脏功能。
Biomacromolecules. 2017 Sep 11;18(9):2820-2829. doi: 10.1021/acs.biomac.7b00760. Epub 2017 Aug 7.
3
Inhibition of CD34+ cell migration by matrix metalloproteinase-2 during acute myocardial ischemia, counteracted by ischemic preconditioning.
Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives.用于治疗缺血性心脏病的再生医学:现状与未来展望
Front Cell Dev Biol. 2021 Sep 10;9:704903. doi: 10.3389/fcell.2021.704903. eCollection 2021.
4
Mesenchymal stem cells transfected with anti-miRNA-204-3p inhibit acute rejection after heart transplantation by targeting C-X-C motif chemokine receptor 4 (CXCR4) .用抗miRNA - 204 - 3p转染的间充质干细胞通过靶向C - X - C基序趋化因子受体4(CXCR4)抑制心脏移植后的急性排斥反应。
J Thorac Dis. 2021 Aug;13(8):5077-5092. doi: 10.21037/jtd-21-1293.
5
Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation.修改间充质干细胞移植过程中 SDF-1/CXCR4 相互作用的策略。
Gen Thorac Cardiovasc Surg. 2022 Jan;70(1):1-10. doi: 10.1007/s11748-021-01696-0. Epub 2021 Sep 12.
6
All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart.条条大路通罗马(心脏):细胞疗法产品通过各种途径输送到心脏后的细胞保留和结果。
J Am Heart Assoc. 2021 Apr 20;10(8):e020402. doi: 10.1161/JAHA.120.020402. Epub 2021 Apr 6.
7
Plasmatic Membrane Expression of Adhesion Molecules in Human Cardiac Progenitor/Stem Cells Might Explain Their Superior Cell Engraftment after Cell Transplantation.人心脏祖细胞/干细胞中黏附分子的质膜表达可能解释了它们在细胞移植后卓越的细胞植入能力。
Stem Cells Int. 2020 Oct 10;2020:8872009. doi: 10.1155/2020/8872009. eCollection 2020.
8
The use of stem cells in ischemic heart disease treatment.干细胞在缺血性心脏病治疗中的应用。
Kardiochir Torakochirurgia Pol. 2018 Sep;15(3):196-199. doi: 10.5114/kitp.2018.78446. Epub 2018 Sep 24.
急性心肌缺血期间基质金属蛋白酶-2对CD34+细胞迁移的抑制作用,可被缺血预处理抵消。
F1000Res. 2016 Nov 22;5:2739. doi: 10.12688/f1000research.9957.3. eCollection 2016.
4
Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury.在慢性缺血再灌注损伤猪模型中,冠状动脉内和心肌内递送后心脏干/祖细胞生物分布和滞留的非侵入性体内成像。
J Transl Med. 2017 Mar 13;15(1):56. doi: 10.1186/s12967-017-1157-0.
5
Sequential activation of different pathway networks in ischemia-affected and non-affected myocardium, inducing intrinsic remote conditioning to prevent left ventricular remodeling.缺血区和非缺血区不同通路网络的序贯激活,诱导内在远程适应,防止左心室重构。
Sci Rep. 2017 Mar 7;7:43958. doi: 10.1038/srep43958.
6
Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials.分娩途径调节间充质干细胞治疗心肌梗死的疗效:一项临床前研究和临床试验的荟萃分析。
Circ Res. 2017 Mar 31;120(7):1139-1150. doi: 10.1161/CIRCRESAHA.116.309819. Epub 2016 Dec 28.
7
A New Paradigm in Cardiac Regeneration: The Mesenchymal Stem Cell Secretome.心脏再生的新范式:间充质干细胞分泌组
Stem Cells Int. 2015;2015:765846. doi: 10.1155/2015/765846. Epub 2015 May 5.
8
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.基于个体患者数据的急性心肌梗死患者细胞心肌研究的荟萃分析(ACCRUE)
Circ Res. 2015 Apr 10;116(8):1346-60. doi: 10.1161/CIRCRESAHA.116.304346. Epub 2015 Feb 19.
9
Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion in the Equine Model.外周血来源的间充质基质细胞通过旁分泌刺激马模型中血管内皮生长因子的分泌促进血管生成。
Stem Cells Transl Med. 2014 Dec;3(12):1514-25. doi: 10.5966/sctm.2014-0138. Epub 2014 Oct 13.
10
Myocardial matrix metalloproteinase-2: inside out and upside down.心肌基质金属蛋白酶-2:由内而外及上下颠倒
J Mol Cell Cardiol. 2014 Dec;77:64-72. doi: 10.1016/j.yjmcc.2014.09.016. Epub 2014 Sep 28.